BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors
Open Access
- 22 October 2012
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 488
Abstract
Background: As major regulators of normal chondrogenesis, the bone morphogenic protein (BMP) and transforming growth factor β (TGFB) signaling pathways may be involved in the development and progression of central chondrosarcoma. In order to uncover their possible implication, the aim of this study was to perform a systematic quantitative study of the expression of BMPs, TGFBs and their receptors and to assess activity of the corresponding pathways in central chondrosarcoma. Methods: Gene expression analysis was performed by quantitative RT-PCR in 26 central chondrosarcoma and 6 healthy articular cartilage samples. Expression of endoglin and nuclear localization of phosphorylated Smad1/5/8 and Smad2 was assessed by immunohistochemical analysis. Results: The expression of TGFB3 and of the activin receptor-like kinase ALK2 was found to be significantly higher in grade III compared to grade I chondrosarcoma. Nuclear phosphorylated Smad1/5/8 and Smad2 were found in all tumors analyzed and the activity of both signaling pathways was confirmed by functional reporter assays in 2 chondrosarcoma cell lines. Immunohistochemical analysis furthermore revealed that phosphorylated Smad1/5/8 and endoglin expression were significantly higher in high-grade compared to low-grade chondrosarcoma and correlated to each other. Conclusions: The BMP and TGFβ signaling pathways were found to be active in central chondrosarcoma cells. The correlation of Smad1/5/8 activity to endoglin expression suggests that, as described in other cell types, endoglin could enhance Smad1/5/8 signaling in high-grade chondrosarcoma cells. Endoglin expression coupled to Smad1/5/8 activation could thus represent a functionally important signaling axis for the progression of chondrosarcoma and a regulator of the undifferentiated phenotype of high-grade tumor cells.Keywords
This publication has 39 references indexed in Scilit:
- Correlation of hypoxic signalling to histological grade and outcome in cartilage tumoursHistopathology, 2010
- Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesisJournal of Experimental Medicine, 2010
- A role for age-related changes in TGFβ signaling in aberrant chondrocyte differentiation and osteoarthritisArthritis Research & Therapy, 2010
- Autocrine Bone Morphogenetic Protein-9 Signals through Activin Receptor-like Kinase-2/Smad1/Smad4 to Promote Ovarian Cancer Cell ProliferationCancer Research, 2009
- Molecular characterization of commonly used cell lines for bone tumor research: A trans‐European EuroBoNet effortGenes, Chromosomes and Cancer, 2009
- Bone morphogenetic protein receptors and signal transductionThe Journal of Biochemistry, 2009
- Changes in surface markers of human mesenchymal stem cells during the chondrogenic differentiation and dedifferentiation processes in vitroArthritis & Rheumatism, 2009
- BMP canonical Smad signaling throughSmad1andSmad5is required for endochondral bone formationDevelopment, 2009
- Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13Bone, 2009
- Signaling cross-talk between TGF-β/BMP and other pathwaysCell Research, 2008